Preliminary clinical evaluation of Portulaca oleraceae seed on treatment of dyslipidemia in adolescents
- Conditions
- Dyslipidemia.Hyperlipidaemia,unspecified
- Registration Number
- IRCT201109122306N4
- Lead Sponsor
- Vice chancellery for research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
1)adolescents between 12 to 18 years old that have at least one of these criteria: a: triglyceride more than 90 percentile b: total cholesterol more than 90 percentile c: LDL more than 90 percentile d:HDL less than 10 percentile 2) Not using tobacco 3) No history of alcohol consumption or drug abuse 4) No history of metabolic diseases like diabetes, thyroid gland dysfunction, nephrotic syndrome, chronic pancreatitis, liver and gall bladder diseases that affects lipid profiles 5) No use of drugs which affect lipid profiles like statins and hormonal pills like estrogens, progestrones and oral contraceptives. Exclusion criteria: 1) Lack of patient’s compliance with drug regimens at least for one week. 2) Pregnancy and lactation 3) Drug sensitivity 4) Suffering from any diseases which interact with lipid profiles 5) Intake of any kind of drugs or other compounds lowering lipid profile like corticosteroids, androgens, estrogenes, progestines, thiazides, beta blockers and thyroid hormones
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HDL cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;LDL cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;Triglyceride. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.;Total cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit.
- Secondary Outcome Measures
Name Time Method